HETEROCYCLYC SULFONAMIDES HAVING EDG-1 ANTAGONISTIC ACTIVITY
申请人:Grewal Gurmit
公开号:US20100029643A1
公开(公告)日:2010-02-04
The invention relates to chemical compounds of formula (I), (Ia) and (Ib) or pharmaceutically acceptable salts thereof, which possess Edg-1 antagonistic activity and are accordingly useful for their anti-cancer activity and thus in methods of treatment of the human or animal body. The invention also relates to processes for the manufacture of said chemical compounds, to pharmaceutical compositions containing them and to their use in the manufacture of medicaments for use in the production of an anti-cancer effect in a warm-blooded animal, such as man.
Chemo-enzymatic site-specific modification of peptides and proteins to form cleavable conjugates
申请人:Northeastern University
公开号:US11129790B2
公开(公告)日:2021-09-28
A method is provided for reversibly modifying a protein or peptide on its glutamine residue(s) by performing a reaction, such as a transglutaminase-catalyzed reaction, between the protein or peptide and an amine-containing reagent, whereby the reagent is linked through its amine function to a side chain of the glutamine residue. Subjecting the modified protein to an appropriate stimulus regenerates the protein or peptide in its original form.
WILCOX, MAXU;VIOLA, RANDALL W.;JOHNSON, KATHERINE W.;BILLINGTON, ANDREW P+, J. ORG. CHEM., 55,(1990) N, C. 1585-1589
作者:WILCOX, MAXU、VIOLA, RANDALL W.、JOHNSON, KATHERINE W.、BILLINGTON, ANDREW P+
DOI:——
日期:——
HETEROCYCLYC SULFONAMIDES HAVING EDG-I ANTAGONISTIC ACTIVITY
申请人:AstraZeneca AB
公开号:EP2094670A1
公开(公告)日:2009-09-02
Chemo-Enzymatic Site-Specific Modification of Peptides and Proteins to Form Cleavable Conjugates
申请人:Northeastern University
公开号:US20180369131A1
公开(公告)日:2018-12-27
A method is provided for reversibly modifying a protein or peptide on its glutamine residue(s) by performing a reaction, such as a transglutaminase-catalyzed reaction, between the protein or peptide and an amine-containing reagent, whereby the reagent is linked through its amine function to a side chain of the glutamine residue. Subjecting the modified protein to an appropriate stimulus regenerates the protein or peptide in its original form.